Last reviewed · How we verify
NCT05506189
Life Style Modification for Breast Canccer Survivors Using Mobile App-based Human Coaching Program
trial testing mobile application program with human coach in Breast Cancer Survivors in 130 participants. Completed in 30 June 2022.
31 December 2021
Quick facts
| Lead sponsor | National Cancer Center, Korea |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 130 |
| Start date | 14 May 2019 |
| Primary completion | 31 December 2021 |
| Estimated completion | 30 June 2022 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- mobile application program with human coach
Conditions studied
- Breast Cancer Survivors — all drugs for Breast Cancer Survivors →
Sponsor
National Cancer Center, Korea
Who can join
Adults 18 to 70, female only, with Breast Cancer Survivors. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is aimed to investigate whether mobile app-based human coaching program for 6 months is effective for reducing BMI in breast cancer survivors with overweight and obesity.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05506189
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Cancer Survivors
Currently open trials in the same condition.
- NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
- NCT07334626 — Impact of Pilates Exercises on Bone Mineral Density in Breast Cancer Survivors Receiving Hormonal Therapy · NA · recruiting
- NCT07280143 — The Development of MASLD Among Survivors of Breast or Colorectal Cancer · recruiting
- NCT07214883 — UCF MammoChat: Image Repository · recruiting
- NCT07284030 — Psychoeducation and Well-Being After Breast Cancer · NA · recruiting
Other National Cancer Center, Korea trials
Trials by the same sponsor.
- NCT07399561 — Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy · NA · not yet recruiting
- NCT07121478 — Patients With High-grade Pancreatic Neuroendocrine Tumors · Phase 2 · enrolling by invitation
- NCT07171528 — Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer · Phase 2 · recruiting
- NCT07125924 — Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer · NA · not yet recruiting
- NCT07041515 — Knowledge-enhanced Digital Intervention to Prevent Low Anterior Resection Syndrome · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05506189 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Cancer Center, Korea
- Last refreshed: 18 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05506189.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing